
Elanco Animal Health Incorporated (NYSE:ELAN) reported third-quarter 2025 results on Wednesday, posting adjusted earnings per share of 19 cents, up 46% year over year.
Earnings exceeded both the company's guidance range of 12-16 cents and the consensus estimate of 13 cents.